Multiple Sclerosis

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Multiple Sclerosis
x

Are you interested in possibly participating in a clinical trial for Warm Autoimmune Hemolytic Anemia?

Read More

Following specialists treat  Multiple Sclerosis. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month


Submit

100%

50%

50%

100%

0%20%40%60%80%

Specialty scores for Multiple Sclerosis

Overview

FDA Approved Medicines

  • FDA approved interferon beta-1a, sold as Rebif, manufactured by Serono Laboratories as subcutaneous injection for the treatment of relapsing forms of multiple sclerosis ( Multiple Sclerosis ) in year 2002.
  • FDA approved mitoxantrone hydrochloride, sold as Novantrone, manufactured by Immunex for reducing neurologic disability and/or the frequency of clinical relapses in patients with multiple sclerosis ( Multiple Sclerosis ) in year 2000.
  • FDA approved dalfampridine, sold as Ampyra, manufactured by Acorda for the improvement of walking in patients with multiple sclerosis ( Multiple Sclerosis ) in year 2010.
  • FDA approved teriflunomide, sold as Aubagio, manufactured by Sanofi Aventis for the treatment of multiple sclerosis ( Multiple Sclerosis ) in year 2012.
  • FDA approved Interferon Beta 1-A, sold as Avonex, manufactured by Biogen IDEC for the treatment of multiple sclerosis ( Multiple Sclerosis ) in year 1995.
  • FDA approved dimethyl fumarate, sold as Tecfidera, manufactured by Biogen Idec for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2013.
  • FDA approved alemtuzumab, sold as Lemtrada, manufactured by Genzyme for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2014.
  • FDA approved fingolimod, sold as Gilenya, manufactured by Novartis for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2010.
  • FDA approved Interferon beta-l b, sold as Extavia, manufactured by Novartis for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2009.
  • FDA approved peginterferon beta-1a, sold as Plegridy, manufactured by Biogen IDEC. for the treatment of relapsing multiple sclerosis ( Multiple Sclerosis | Primary Progressive Multiple Sclerosis ) in year 2014.